Cel-Sci (CVM) vs Genenta Science S.p.A. (GNTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Genenta Science S.p.A. (GNTA) has outperformed Cel-Sci (CVM) over the past year, losing 76.1% versus a loss of 79.1%. Cel-Sci is the larger company by market cap ($34.3 million vs $34.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVM | GNTA |
|---|---|---|
| Share price | $1.95 | $0.7101 |
| Market cap | $34.30M | $34.24M |
| 1-day change | -8.45% | -5.95% |
| YTD return | -59.51% | -49.33% |
| 1-year return | -79.12% | -76.11% |
| 5-year return | -99.32% | — |
| EPS (TTM) | $-1.69 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.39 | $10.00 |
| 52-week low | $0.89 | $0.55 |
| Distance from 52-week high | -81.23% | -92.90% |
| Average volume | 241.50K | 61.48K |
| Shares outstanding | 17.59M | 48.22M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CVM vs GNTA FAQ
Which is bigger, Cel-Sci or Genenta Science S.p.A.?
Cel-Sci (CVM) is larger, with a market capitalization of $34.30M compared with $34.24M for Genenta Science S.p.A. (GNTA).
Which stock has performed better over the past year, CVM or GNTA?
GNTA returned -76.11% over the past 12 months, compared with -79.12% for CVM (price return, excluding dividends). Past performance does not predict future results.
Are Cel-Sci and Genenta Science S.p.A. in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.